I've given up on it they've always been really bad at selling the company to the market.
It's all good to run the big number of presentations each year but they are not the people that price the company the market prices the company. If you want the share price higher you need to sell it to the market if you're not doing that then it's pointless to keep trying to run the poor cousin story against peers trading at many multiples the value.
Slipping a bit of news into presentations or a couple of lines in newsletters & or the annual report isn't selling it to market - if you haven't sold it to market then it's unlikely anybody apart from current shareholders are reading any of it.
They need to swap those couple of lines snuck into wider documents for their own page.
OMOMYC , Journal Pub + Media re stroke are the two most recent examples but then things like the Biosenser how long has that been 18 months ? Sox18 ? Sonic Hedgehog Pathway ?
They need to sell their strengths to market if they want to be valued appropriately.
They will get more interest from brokers when presenting conferences if they've got the market behind them.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)